The Increasing Necessity for Market-Based Pharmaceutical Prices*
- 1 January 2000
- journal article
- review article
- Published by Springer Nature in PharmacoEconomics
- Vol. 18 (Supplement) , 47-57
- https://doi.org/10.2165/00019053-200018001-00007
Abstract
In most markets, research and development are driven by expected prices, and those prices are determined mainly by consumer willingness to pay for the potential benefits of new products. In the...Keywords
This publication has 28 references indexed in Scilit:
- Why Don't Physicians Follow Clinical Practice Guidelines?JAMA, 1999
- German doctors are unhappy about drugs budgetBMJ, 1999
- Clinical Outcomes in Statin Treatment TrialsArchives of internal medicine (1960), 1999
- Aggressive Lipid-Lowering Therapy Compared with Angioplasty in Stable Coronary Artery DiseaseNew England Journal of Medicine, 1999
- Statins being prescribed for those "least in need"BMJ, 1999
- Pharmacotherapy for ObesityPublished by American Medical Association (AMA) ,1999
- Inadequate Management of Blood Pressure in a Hypertensive PopulationNew England Journal of Medicine, 1998
- Workplace performance effects from chronic depression and its treatmentJournal of Health Economics, 1998
- Book Review Lipids: Current perspectives Edited by D. John Betteridge. 302 pp. St. Louis, Mosby, 1996. $75. 1-85317-231-6New England Journal of Medicine, 1997
- Trends in Drug Development Costs, Times, and RisksDrug Information Journal, 1995